Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research
International Journal of Molecular Sciences · 11.03.2023 · 24 (6) · 5377
DOI: 10.3390/ijms24065377 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.03.2023. Verfasst von Rafał Skopek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postępu 36A, 05-552 Magdalenka, Poland. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Science Centre.
Abstract (Originalsprache)
Immortalized cell lines are widely used in vitro tools in oncology and hematology research. While these cell lines represent artificial systems and may accumulate genetic aberrations with each passage, they are still considered valuable models for pilot, preliminary, and screening studies. Despite their limitations, cell lines are cost-effective and provide repeatable and comparable results. Choosing the appropriate cell line for acute myeloid leukemia (AML) research is crucial for obtaining reliable and relevant results. Several factors should be considered when selecting a cell line for AML research, such as specific markers and genetic abnormalities associated with different subtypes of AML. It is also essential to evaluate the karyotype and mutational profile of the cell line, as these can influence the behavior and response to the treatment of the cells. In this review, we evaluate immortalized AML cell lines and discuss the issues surrounding them concerning the revised World Health Organization and the French–American–British classifications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Postępu 36A, 05-552 Magdalenka, Poland.
- Department of Physiological Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, 02-787 Warsaw, Poland.
- Polbionica Sp. z.o.o., Aleja Prymasa Tysiąclecia 79A, 01-242 Warsaw, Poland.
- Department of Hematology and Medical Oncology, Clinic of Internal Medicine II, Jena University Hospital, 07747 Jena, Germany.
- Institute of Molecular Cell Biology, Center for Molecular Biomedicine Jena (CMB), Jena University Hospital, 07747 Jena, Germany.
- Faculty of Medical Sciences and Health Sciences, Kazimierz Pulaski University of Technology and Humanities, 26-600 Radom, Poland.
ORCID-Profile: Rafał Skopek, Małgorzata Palusińska, Rafał Pingwara, Anna Papierniak-Wyglądała, Sławomir Lewicki, Łukasz Szymański
Förderung
- the National Science Centre
Zitieren
APA
Skopek, R., Palusińska, M., Kaczor-Keller, K., Pingwara, R., Papierniak-Wyglądała, A., Schenk, T., Lewicki, S., Zelent, A., & Szymański, Ł. (2023). Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. International Journal of Molecular Sciences, 24(6), 5377. https://doi.org/10.3390/ijms24065377
Vancouver
Skopek R, Palusińska M, Kaczor-Keller K, Pingwara R, Papierniak-Wyglądała A, Schenk T, et al. Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. International Journal of Molecular Sciences. 2023;24(6):5377. doi:10.3390/ijms24065377
BibTeX
@article{Skopek2023,
author = {Skopek, Rafał and Palusińska, Małgorzata and Kaczor-Keller, Katarzyna and Pingwara, Rafał and Papierniak-Wyglądała, Anna and Schenk, Tino and Lewicki, Sławomir and Zelent, Artur and Szymański, Łukasz},
title = {Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5377},
doi = {10.3390/ijms24065377}
}
EUVIMED